Ekso Bionics
Bay Area exoskeleton developer for rehabilitation and industrial use, now a subsidiary of ChronoScale.
Ekso Bionics develops exoskeletons that support or boost strength, endurance and mobility for medical rehabilitation and for industrial workers. Its systems range from devices that help people with paralysis stand and walk to tools for job site use, and the company is based in San Rafael in the San Francisco Bay Area. In October 2025 it priced a registered direct sale of 769,490 shares at $4.81 each, for which it projected about $3.7 million in gross proceeds. In January 2026 it priced a private placement of Series B preferred stock and warrants with expected gross proceeds of roughly $5.9 million. On May 5, 2026 Applied Digital contributed its cloud business to the listed Ekso entity, which was renamed ChronoScale Corporation and began trading on Nasdaq as CHRN, with Applied Digital owning about 97%. The original exoskeleton business continues to operate as a wholly owned subsidiary of ChronoScale.
- Latest funding
- —
- Total funding
- —
- Latest valuation
- —
- Founded
- —
- Country
- United States
- Jan 21, 2026Private placement (Series B preferred)—
- Oct 29, 2025Registered direct offering—